Hemant Surgical Industries Completes Acquisition of Lifesenz Cancer Research Labs, Forms Subsidiary
Hemant Surgical Industries Ltd. announced the successful completion of its acquisition of Lifesenz Cancer Research Labs Private Limited. The transaction, which took place on June 01, 2026, marks a significant expansion for the medical device firm.Following the completion of the acquisition, Hemant Surgical Industries Ltd. stated that Lifesenz Cancer Research Labs Private Limited, located in Mumbai, has officially become a subsidiary of the company. This new relationship status is effective from June 01, 2026.
Stock Price Movement
As of 14:30, shares of Hemant Surgical Industries Ltd are shedding nearly 2.18% today, moving to trade at ₹395.00. The stock has traded through a significant intraday range, testing lows of ₹384.15 while also reaching a high of ₹409.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.